Federal Circuit: Specific Personal Jurisdiction Exists Over Mylan In Patent Case
WASHINGTON, D.C. — Acting on interlocutory appeal, the Federal Circuit U.S. Court of Appeals on March 18 affirmed findings by two Delaware federal judges that Mylan Pharmaceuticals Inc. must face patent...To view the full article, register now.
Already a subscriber? Click here to view full article